Gainers

  • Longfin Corp.LFIN shares surged 47.3 percent to close at $28.189 on Friday after climbing 64.86 percent on Thursday.
  • Genprex, Inc. GNPXjumped 31.74 percent to close at $5.45 on Friday.
  • Broadwind Energy, Inc.BWEN shares gained 28.94 percent to close at $3.03 after the company disclosed that it has recently booked $10 million in new tower orders and Gearing segment orders of $15 million in Q1.
  • Marrone Bio Innovations, Inc. MBIIshares jumped 21.72 percent to close at $3.25.
  • NuCana plcNCNA shares gained 16.94 percent to close at $26.23.
  • CASI Pharmaceuticals, Inc. CASIshares rose 13.98 percent to close at $7.01 on Friday.
  • FTD Companies, Inc. FTDshares climbed 13.33 percent to close at $5.10.
  • GOL Linhas Aéreas Inteligentes S.A. GOLshares gained 12.97 percent to close at $14.11 on Friday. Bank of America upgraded Gol Linhas from Neutral to Buy.
  • Pacira Pharmaceuticals, Inc. PCRXshares rose 12.88 percent to close at $33.30. Pacira reported the FDA approval of supplemental new drug application for EXPAREL.
  • Radiant Logistics, Inc. RLGTgained 10.08 percent to close at $4.04.
  • Freshpet, Inc. FRPTshares rose 10.06 percent to close at $18.05 on Friday.
  • BIO-key International, Inc. BKYIshares gained 9.59 percent to close at $2.40.
  • NII Holdings, Inc. NIHDshares climbed 6.61 percent to close at $2.42.
  • PriceSmart, Inc.PSMT gained 5.5 percent to close at $88.225 after the company reported stronger-than-expected results for its second quarter on Thursday.


Losers

  • NewLink Genetics Corporation NLNKshares tumbled 42.62 percent to close at $4.20 on Friday.
  • MannKind Corporation MNKDfell 24.79 percent to close at $1.79. MannKind priced its 14 million share registered direct offering at $2 per share.
  • Incyte CorporationINCY declined 22.93 percent to close at $64.02 after the company , announced Friday a disappointing update to a phase 3 trial. Incyte said its experimental therapy called epacadostat failed in a phase 3 trial called ECHO-301 to improve the efficacy of Merck & Co’s Keytruda when the two therapies were combined to treat patients suffering from melanoma.
  • Allena Pharmaceuticals, Inc. ALNAshares dipped 19.5 percent to close at $12.67.
  • Innovate Biopharmaceuticals, Inc. INNTtumbled 19.21 percent to close at $27.68.
  • Syndax Pharmaceuticals, Inc. SNDXshares fell 18.74 percent to close at $10.84.
  • Boston Omaha CorporationBOMN shares dipped 17.86 percent to close at $22.40.
  • Net Element, Inc.NETE shares fell 17.36 percent to close at $7.33 on Friday after jumping 32.98 percent on Thursday.
  • Luna Innovations IncorporatedLUNA shares dropped 15.92 percent to close at $3.17.
  • Finjan Holdings, Inc. FNJNfell 15.68 percent to close at $2.85.
  • Northern Oil and Gas, Inc.NOG dipped 14.45 percent to close at $1.48. Northern Oil and Gas priced 58.67 million shares at $1.50 per share.
  • Sunrun Inc.RUN shares fell 14.29 percent to close at $8.52. Bank of America downgraded Sunrun from Buy to Underperform.
  • resTORbio, Inc.TORC fell 11.29 percent to close at $8.49.
  • Iteris, Inc. ITIshares fell 9.46 percent to close at $4.50 on Friday.
  • New Media Investment Group Inc.NEWM fell 6.38 percent to close at $16.30. New Media Investment Group priced its 6 million share offering at $16.5 per share.
  • ORBCOMM IncORBC fell 4.01 percent to close at $8.85. ORBCOMM priced its 3 million share common stock offering at $8.60 per share.